Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 13.07
(0.31%)
CNY 13.07
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.14 Billion | 1.2 Billion | 705.27 Million | 114.19 Million | 62.01 Million | -65.22 Million |
| Net Income | 419.39 Million | 938.22 Million | 601.35 Million | 1.21 Billion | 194.13 Million | 1.06 Billion |
| Depreciation & Amortization | 333.33 Million | 264.93 Million | 143.83 Million | 123.94 Million | 76.62 Million | 115.71 Million |
| Deferred income taxes | -831.86 Thousand | 29.54 Million | -6.53 Million | 1.7 Million | -88.35 Million | -103.01 Million |
| Stock-based compensation | - | -38.79 Million | 84.75 Million | 79.28 Million | 67.49 Million | 19.1 Million |
| Change in working capital | -193.07 Million | -315.4 Million | -249.02 Million | -908.62 Million | -137.25 Million | -139.35 Million |
| Other non-cash items | 1.44 Billion | 245.4 Million | 130.89 Million | -393.29 Million | -50.64 Million | -1.1 Billion |
| Investing Cash Flow | -810.27 Million | -935.18 Million | -977.14 Million | -729.99 Million | 192.99 Million | 619.13 Million |
| Investments in PPE | -945.51 Million | -1.09 Billion | -1.1 Billion | -407.13 Million | -351.82 Million | -227.32 Million |
| Acquisitions | 145.23 Million | 149.38 Million | 75.68 Million | 75 Million | 567.48 Million | 1.18 Billion |
| Investment purchases | -10 Million | 1.78 | -62.46 Million | -407.55 Million | -26.5 Million | -389 Million |
| Sales/Maturities of investments | 6.78 Million | 6.26 Million | 109.38 Million | 5.21 Million | 3.63 Million | 46.06 Million |
| Other Investing Activities | -6.78 Million | 342.36 Thousand | 3.73 Million | 4.47 Million | 199.57 Thousand | 432.49 Thousand |
| Financing Cash Flow | 232.19 Million | 94.81 Million | 1.73 Billion | 215.07 Million | -360.63 Million | 711.69 Million |
| Debt repayment | -351.03 Million | -390 Million | -140 Million | -40 Million | -30 Million | -220 Million |
| Dividends payments | -19.98 Million | -43.24 Million | -78.3 Million | -30.86 Million | -46.12 Million | -4.45 Million |
| Common Stock Repurchased | -72.21 Million | -286.41 Million | - | - | - | - |
| Common Stock Issuance | - | 286.41 Million | - | - | - | - |
| Other Financing Activities | -3.12 Million | 534.92 Million | 1.95 Billion | 286.8 Million | -261.95 Million | 936.15 Million |
| Accounts receivables | 535.7 Million | -1.24 Billion | -614.65 Million | -1.49 Billion | -72.9 Million | -215.43 Million |
| Accounts payables | -593.87 Million | 1.07 Billion | 762.19 Million | 755.66 Million | 100.77 Million | 204.74 Million |
| Inventory | -134.9 Million | -178.78 Million | -390.03 Million | -170.51 Million | -76.76 Million | -25.64 Million |
| Other working capital | 1.00 | 29.54 Million | -6.53 Million | 1.7 Million | -88.35 Million | -113.71 Million |
| Cash at beginning of period | 3.87 Billion | 3.42 Billion | 1.96 Billion | 2.36 Billion | 2.46 Billion | 1.2 Billion |
| Cash at end of period | 4.36 Billion | 3.79 Billion | 3.42 Billion | 1.96 Billion | 2.36 Billion | 2.46 Billion |
| Capital Expenditure | -945.51 Million | -1.09 Billion | -1.1 Billion | -407.13 Million | -351.82 Million | -227.32 Million |
| Effect of forex changes on cash | 2.27 Million | 4.06 Million | -124.83 Thousand | -1 Million | -209.03 Thousand | 1.6 Million |
| Net cash flow / Change in cash | 491.05 Million | 365.19 Million | 1.46 Billion | -401.72 Million | -105.83 Million | 1.26 Billion |
| Free Cash Flow | 194.98 Million | 110.31 Million | -398.2 Million | -292.93 Million | -289.8 Million | -292.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.79 Million | 156.43 Million | 14.12 Million | -133.98 Million | 419.39 Million | 98.13 Million |
| Depreciation & Amortization | - | 100.56 Million | 100.56 Million | 78.26 Million | 333.33 Million | -168.93 Million |
| Deferred income taxes | - | - | - | - | -831.86 Thousand | -77.66 Million |
| Stock-based compensation | - | - | - | - | - | -2.01 Million |
| Change in working capital | - | 119.62 Million | - | 400.8 Million | -193.07 Million | 248.62 Million |
| Other non-cash items | 387.83 Million | 110.31 Million | -89.72 Million | -72.29 Million | 1.44 Billion | 377.13 Million |
| Investing Cash Flow | -135.48 Million | -874.58 Million | -162.34 Million | -229.26 Million | -810.27 Million | -256.98 Million |
| Investments in PPE | -140.31 Million | -151.43 Million | -153.54 Million | -224.1 Million | -945.51 Million | -257.14 Million |
| Acquisitions | 5275.00 | 47.13 Thousand | - | 144.84 Million | 145.23 Million | 163.65 Thousand |
| Investment purchases | 700 Million | -723.2 Million | -8.8 Million | -10 Million | -10 Million | - |
| Sales/Maturities of investments | - | - | - | -140 Million | 6.78 Million | - |
| Other Investing Activities | 4.82 Million | -723.15 Million | -8.8 Million | -9.65 Million | -6.78 Million | 0.50 |
| Financing Cash Flow | -33.91 Million | -69.82 Million | -14.22 Million | 238.45 Million | 232.19 Million | -6.07 Million |
| Debt repayment | -20.3 Million | -45.94 Million | -147.34 Thousand | -148.61 Million | -351.03 Million | -28.42 Million |
| Dividends payments | -6.29 Million | -18.56 Million | -2.47 Million | -15.99 Million | -15.99 Million | -1.2 Million |
| Common Stock Repurchased | - | - | - | -72.21 Million | -72.21 Million | 72.21 Million |
| Common Stock Issuance | - | - | - | - | - | -72.21 Million |
| Other Financing Activities | -7.32 Million | -11.58 Million | -14.07 Million | 205.55 Million | -3.12 Million | 23.55 Million |
| Accounts receivables | - | 97.14 Million | - | 535.7 Million | 535.7 Million | 102.39 Million |
| Accounts payables | - | - | - | - | -593.87 Million | - |
| Inventory | - | 22.47 Million | - | -134.9 Million | -134.9 Million | 146.22 Million |
| Other working capital | - | - | - | - | 1.00 | - |
| Cash at beginning of period | 3.32 Billion | 4.11 Billion | 4.36 Billion | 4.08 Billion | 3.87 Billion | 3.85 Billion |
| Cash at end of period | 3.61 Billion | 3.33 Billion | 4.11 Billion | 4.36 Billion | 4.36 Billion | 4.07 Billion |
| Capital Expenditure | -140.31 Million | -151.43 Million | -153.54 Million | -224.1 Million | -945.51 Million | -257.14 Million |
| Effect of forex changes on cash | -6.29 Million | 743.63 Thousand | 93.3 Thousand | -327.85 Thousand | 2.27 Million | 1.55 Million |
| Net cash flow / Change in cash | 293.1 Million | -777.74 Million | -252.04 Million | 277.87 Million | 491.05 Million | 213.76 Million |
| Free Cash Flow | 333.31 Million | 14.75 Million | -229.14 Million | 48.67 Million | 194.98 Million | 218.12 Million |
PALREDTEC
FONU
003022
GDHG
300813
002694